MoneyWorks4Me

Sanofi India informs about appointment of CFO

05 Oct 2020 Evaluate
As required under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Sanofi India has informed that the Board of Directors of the Company at its meeting held on 5th October 2020 approved appointment of Vaibhav Karandikar as Chief Financial Officer (CFO) and Key Managerial Personnel with effect from 6th October 2020. A brief profile of Vaibhav Karandikar is enclosed.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..